Adverse Events of Cannabidiol Use in Patients With Epilepsy
Abstract Question: What are the frequency and risk of adverse events (AEs) developing in patients with epilepsy who are using…
Abstract Question: What are the frequency and risk of adverse events (AEs) developing in patients with epilepsy who are using…
Abstract Deep eutectic solvents (DESs) are a class of sustainable solvents that have found numerous applications in different fields. One…
Abstract Introduction: Ethanolic fraction of Moroccan Cannabis sativa threshing residues (EFCS) was evaluated for its vasorelaxant activity. The current work…
Abstract Introduction: Despite US FDA approval of cannabidiol (CBD) liquid (Epidiolex®), patients with epilepsy still supplement prescription treatments with dispensary…
Abstract Recall difficulty on survey items varied with participant’s use frequency. Difficulties emerged in reporting quantity of cannabis used over…
Abstract JWH-018 is the most known compound among synthetic cannabinoids (SCs) used for their psychoactive effects. SCs-based products are responsible…
Abstract Purpose: Although medicinal cannabis is prescribed for conditions such as pain, epilepsy, nausea and vomiting during cancer treatment, evidence…
Abstract The treatment of chronic pain with cannabinoids is becoming more widespread and popular among patients. However, studies show that…
Abstract Background: “FODMAPs” (fermentable-oligo-, di-, monosaccharides, and polyols) are a group of fermentable carbohydrates and polyols largely diffused in food…
Abstract Recent changes in cannabis accessibility have provided adjunct therapies for patients across numerous disease states and highlights the urgency…